Hunniwell Lake Ventures Spotlights NuvOx Hunniwell Lake Ventures interviews NuvOx Co-founder and CEO, Evan Unger MD.
Health Canada Allows Phase IIa Clinical Trial in COVID-19 Patients with Respiratory Failure Health Canada allows a Phase IIa Trial in COVID-19 patients with Respiratory Failure
NuvOx Expands Production Line NuvOx Pharma is breaking ground on an addition to its manufacturing facility. Read full story
NuvOx Pharma’s NanO2 Shows Positive Results in Phase Ib/II Stroke Trial Positive results of NuvOx Pharma’s NanO2 (DDFPe) in the treatment of stroke have been published at the International Stroke Conference. A...
NuvOx Wins TechConnect Defense Innovation Award NuvOx was awarded the TechConnect Defense Innovation Award based on the potential impact the technology will have on national security.
NuvOx Pharma wins AZBio Fast Lane Award NuvOx was honored with the AZBIO Fast Lane Award for the company's many achievements in the last 18 months.
National Cancer Institute Grants $3M to NuvOx Pharma for Phase II Clinical Trial in Brain Cancer The NCI Grants $3M to NuvOx for a Phase II clinical trial in the brain cancer, glioblastoma.
NuvOx Wins MedCity INVEST Perfect Pitch Contest NuvOx Pharma wins 1st place out of the biopharma companies at the MedCity INVEST Perfect Pitch Contest.
NuvOx wins Venture Madness competition and $60,000 prize. NuvOx wins 1st place out of 113 entrants and a $60,000 cash prize.
